Puerarin inhibits cardiac fibrosis via monocyte chemoattractant protein (MCP)-1 and the transforming growth factor-β1 (TGF-β1) pathway in myocardial infarction mice

Transforming growth factor-β1 (TGF-β1) and inflammation play important roles in the cardiac fibrosis development associated with myocardial infarction (MI). Puerarin is wildly used for treatment of diabetes, cardiovascular disease and cerebrovascular disease in China, and recently some studies have...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Am J Transl Res
Päätekijät: Tao, Zhiwen, Ge, Yingbin, Zhou, Ningtian, Wang, Yunle, Cheng, Weili, Yang, Zhijian
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: e-Century Publishing Corporation 2016
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5095335/
https://ncbi.nlm.nih.gov/pubmed/27830026
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia